Mandate

Vinge advises Infracapital on the acquisition of Falbygdens Energi

December 02, 2013

Vinge is advising Infracapital, a leading European infrastructure investor, managed by M&G Investment Management, the European investment management arm of Prudential plc in connection with the acquisition of Falbygdens Energi AB from Göteborg Energi AB.

Falbygdens Energi AB operates primarily within the Swedish municipality of Falköping. The business operations comprise mainly of the production and distribution of district heating and the distribution of electricity in the area. The electricity distribution network comprises 522 kilometres of overhead lines and 1,690 kilometres of underground cables. FEAB also operates a broadband business in the municipality.

Johan Göthberg was the responsible partner together with associates Matthias Pannier, Lisa Antman, Joel Zetterström, Gabriel Westin, Emma Kero Ljungberg and counsel Robert Deli. Partner Thomas Sjöberg and associate Sofia Ekdahl are advising on real estate and environmental questions.

Related

Vinge advises Right Side Group, a portfolio company of Alder, in connection with the acquisition of Brandkonsultbyrån i Sverige

Brandkonsultbyrån in Sweden is a technical consultant specialising in structural fire protection, evacuation safety and risk management. The acquisition strengthens the group’s position as a leading player in fire, risk and safety in the Nordic region.
April 17, 2026

Vinge advises Vidia Climate Fund I in connection with the acquisition and acquisition financing of ABEKA El & Kraftanläggningar AB

Vinge has acted as legal adviser to Vidia Climate Fund I in connection with the acquisition and acquisition financing of ABEKA El & Kraftanläggningar AB from Bravida and certain minority shareholders. ABEKA El & Kraftanläggningar AB is a highly specialized electrical grid services and project management provider.
April 17, 2026

Vinge adviser in the sale of SAGA Diagnostics

Vinge acted as legal adviser relating to Swedish law in connection with the sale of SAGA Diagnostics to Roche’s subsidiary Foundation Medicine.
April 16, 2026